UPDATE: Baird Downgrades Walgreens Boosts Alliance (WBA) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Walgreens Boosts Alliance (WBA) PT Lowered to $46 at RBC Capital
April 1, 2022 6:10 AM EDTRBC Capital analyst Anton Hie lowered the price target on Walgreens Boosts Alliance (NASDAQ: WBA) to $46.00 (from $52.00) while maintaining a Sector Perform rating.... More
Walgreens Boosts Alliance (WBA) PT Lowered to $48 at Evercore ISI
April 1, 2022 4:08 AM EDTEvercore ISI analyst Elizabeth Anderson lowered the price target on Walgreens Boosts Alliance (NASDAQ: WBA) to $48.00 (from $55.00) while maintaining a In Line rating.... More
Walgreens Boots (WBA) Stock Plunges 6% on Unchanged Guidance, Results Still Seen as 'Strong'
March 31, 2022 10:06 AM EDTWalgreens Boots (NASDAQ: WBA) reported FQ2 adjusted EPS of $1.59, beating the consensus estimates of $1.37 per share.
Sales in the period came in at $33.76 billion, also above the consensus projection of $33.32 billion. The company reported U.S. sales of $27.67 billion, almost in line with the expected $27.71 billion. International sales totaled $5.56 billion, below the analyst estimates of $5.68 billion.
The pharmaceutical company reported an adjusted gross... More
Walgreens' upbeat Q2 fails to perk up 2022 profit view; co shares slide
March 31, 2022 7:59 AM EDTBy Bhanvi Satija and Manas Mishra
(Reuters) -Walgreens Boots Alliance Inc kept its 2022 earnings forecast unchanged even as it beat estimates for second-quarter results, sending the drugstore chain's shares down 7% on fears of slower-than-expected growth for the rest of the year.
An Omicron-led surge in COVID-19 cases during the second quarter had boosted demand for vaccines and testing at Walgreens. But testing has slowed since January, Walgreens executives said, adding it remains a... More
Walgreens Boots Alliance (WBA) Tops Q2 EPS by 21c
March 31, 2022 7:01 AM EDTWalgreens Boots Alliance (NASDAQ: WBA) reported Q2 EPS of $1.59, $0.21 better than the analyst estimate of $1.38. Revenue for the quarter came in at $33.76 billion versus the consensus estimate of $33.38 billion.
Fiscal 2022 outlook:
Maintaining full year adjusted EPS guidance of low-single digit... More
